Categories AlphaGraphs, Earnings, Health Care

Biogen tops market estimates in Q3, lowers guidance

Biogen (NASDAQ: BIIB) reported third-quarter 2020 financial results before the opening bell on Wednesday. The biotechnology giant reported a 6% decline in Q3 revenues to $3.38 billion, beating the Wall Street consensus. Earnings of $8.84 per share were also stronger than what analysts had anticipated.

BIIB shares were trading flat immediately following the announcement. The stock has slipped 9% since the beginning of this year.

Biogen Q3 2020 earnings.

Looking forward to listening to management/ analyst comments on Q4 results? Stay tuned here for Biogen Q3 2020 earnings call transcript

Biogen also lowered its guidance for the full year, hurt by multiple Tecfidera generic entrants in the US.

Prior performance

Most Popular

Earnings calendar for the week of May 17

Benchmark stock indexes pared their recent gains early this week amid elevated inflation concerns, but regained a part of the momentum later aided by recovery in tech stocks. The Dow

Alibaba (BABA): The good and the bad from the Q4 earnings report

Shares of Alibaba Group (NYSE: BABA) have dropped 10% since the beginning of the year. The company reported mixed results for the fourth quarter of 2021 a day ago, with

Walt Disney (DIS) is focused on reopening, to put up a better show this year

With some of its parks and resorts either closed or operating at reduced capacity even more than a year after the virus outbreak, The Walt Disney Company (NYSE: DIS) is

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top